Even before COVID-19 inexorably changed social and clinical protocols, dental offices dealt with patients who claimed to “know better” than their providers when it came to health risks. From unvaccinated patients to incomplete health histories, failure to cooperate results in ethical and legal challenges for dentists. In today’s practice environment, these challenges also include navigating interactions with patients who simply refuse to wear face masks.
The relationship between oral health and overall health has been well established for many comorbidities including diabetes and cardiovascular disease.
We are still learning about COVID-19 and how it affects people living with HIV. Based on limited data, people with HIV who are on effective HIV treatment have the same risk for COVID-19 as people who do not have HIV.
We close out 2020 by recognizing the productivity of the AETC community despite this year’s challenges and setbacks. In addition to restructuring and reimagining their clinical settings and AETC-related programming due to the COVID-19 pandemic, AETC members were also researching and reexamining HIV care continuum interventions and healthcare models. The following is a compilation of peer-reviewed studies, and other publications, produced by AETC-affiliated researchers and faculty published during 2019-2020. This list represents the work beyond the walls of the AETC Program.
With the number of Coronavirus cases surpassing 7.3 million and 210,000 deaths in the United States, dental offices continue to be faced with shortages of personal protective equipment (PPE). Surge capacity refers to the ability to manage a sudden increase in patient volume that would severely challenge or exceed the present capacity of a facility. While there are no commonly accepted measurements or triggers to distinguish surge capacity from daily patient care capacity, surge capacity is a useful framework to approach a decreased supply of PPE during the COVID-19 response.
CHICAGO, Oct. 15, 2020 — Although assumed to be at high risk for COVID-19, fewer than one percent of dentists nationwide were found to be COVID-19 positive, according to a first-of-its-kind report in the U.S. based on data collected in June 2020. The result is far below that of other health professionals in the U.S. In addition, 99 percent of dentists are using enhanced infection control procedures such as screening protocols and enhanced disinfection practices when treating patients.
The Native American Community Clinic (NACC) in Minneapolis has been highly successful in integrating HIV care into their Federally Qualified Health Center (FQHC). Minnesota has eleven sovereign American Indian (AI) nations1, and the Phillips neighborhood of Minneapolis (where NACC is located) has the third-largest urban AI population in the United States2.
At the onset of the COVID-19 pandemic, the Northeast/Caribbean (NECA) AIDS Education & Training Center (AETC) found itself in need of a massive shift in its training methods. Within a matter of days, we were faced with shifting all of our in-person learning sessions to an entirely virtual format.
A long-acting formulation of the investigational integrase inhibitor cabotegravir (CAB) is being studied as a single agent for HIV prevention. (CAB also has been studied, in combination with long-acting rilpivirine, as treatment for people with HIV, see Long-Acting Injectable ART: Cabotegravir + Rilpivirine; this combination has been submitted for FDA approval).